CEACAM5 and neoplasm: MEDI-565 (AMG211, MT111), as a BiTE antibody mediating T cell-directed cytotoxicity towards CEA positive tumor cells, was positively correlated with CEA antigen density regardless of the mutational status of the tumor cell lines, including BRAF, KRAS, PTEN, PI3KCA, and TP53 [111].